Live
- A Guide to Temperature and Humidity Standards in Data Center Server Rooms
- Gadwal collector briefs on details of voters
- Jupally Krishna Rao takes part in Alampur rallu
- Bharath Prasad files 3rd Nomination
- Baisakh Month: A Time of Auspicious Beginnings and Sacred Festivals
- Oust BJD govt for overall development, says Shah
- Unveiling the Hidden Gems: Surprising Health Benefits of Garlic Peels
- Overcoming Sleep Struggles: A Comprehensive Guide to a Restful Night
- RTC bus hit the auto
- MLA Kuchukula Rajesh Reddy participated in the Birappa festival
Dr Reddy's launches insomnia treatment tablets
Dr Reddy's Laboratories on Tuesday said it has launched generic Ramelteon tablets used for treatment of insomnia in the US market.
Hyderabad: Dr Reddy's Laboratories on Tuesday said it has launched generic Ramelteon tablets used for treatment of insomnia in the US market.
The company has launched Ramelteon tablets in the strength of 8 mg after getting approval by the United States Food and Drug Administration (USFDA), Dr Reddy's said.
The product is a generic version of Takeda Pharmaceutical Company's Rozerem tablets in the same strength, it added.
The Rozerem brand had the US sales of around $91.3 million MAT (moving annual total) for the most recent 12 months ending in May 2019, the drug major said.
The company's generic 8 mg Ramelteon tablets are available in bottle count sizes of 30, 100 and 1,000, it added.
The tablets are indicated for the treatment of insomnia characterised by difficulty with sleep onset.
